Neurology Flashcards
(169 cards)
first sign myasthenia gravis
diplopia and ptosis
often worse at the end of the day
Mobius syndrome
Congenital palsy of multiple cranial nerves, most often the 6th (abducens) and 7th (facial) nerves.
Normal intelligence
what does floppy weak vs floppy strong refer to ?
when assessing a baby with hyptonia,
floppy strong= low tone but no weakness: central cause, chromosomal, syndromic, metabolic
floppy weak= weak, poor antigravity movements: peripheral cause, neuromuscular disease
which part of the motor unit is affected in spinal muscular atrophy
anterior horn cell
creatinine kinase is raised in …
peripheral causes of neuromuscular disease
There are many peripheral neuromuscular conditions where the CK is always elevated from birth (e.g., in Duchenne and Becker muscular dystrophies, and in some of the congenital muscular dystrophies, and some limb girdle muscular dystrophies) and other conditions where CK is mildly elevated or normal (e,g., spinal muscular atrophy, neuropathies, and congenital myopathies)
also see elevated transaminases in DMD and BMD
SMA genetics
autosomal recessive
Carrier frequency in population 1/50
deletion of exon 7 of the SMN1 gene (chromosome 5)
SMN2- nearly identical to SMN1 but differs at a single nucleotide, which modulates splicing, resulting in a lack of exon 7 from 90% of mRNA transcripts - however does make some functional protein
thus, those with mild disease tend to have more copies, those with severe disease have less copies (eg SMA1 have 2 x SMN2 copies, thoese with SMA4 have >4 copies SMN2)
Subtypes SMA
tongue fasiculations occur in …
SMA (anterior horn cell pathology)
basics of SMA presentation
floppy weak baby with bright alert face
SMA1- present in neonatal period –> hypotonia, poor antigravity movement, weak cry, bulbar dysfunction/feeding difficulties, tongue fascinations, areflexia, respiratory insufficiency, death by 2 years
SMA2- present 6-12 months, sit but dont walk, progressive muscle weakness, orthopaedic complications (scolitosis, contractures, resp weakness (frequent chest infections, nocturnal resp support needed), normal IQ
SMA3- onset 18-24 months, walk unaided but maybe late, can later lose walking ability. Progressive PROXIMAL muscle weakness, especially shoulder girdle, reduced reflexes, tremor
Ix: newborn screening, SMN1 single gene testing or multigene panel (not microarray- deletion is too small to detect)
CK is mildly elevated
SMA treatment
Modulation of the low functioning SMN2 gene
- Nusinersen - intrathecal
-Risdiplam - oral
Nusinrsen
“antisense oligonucleotide therapy”
modifies splicing of SMN2 gene allowing incorporation of exon 7 into SMN2 –> increasing production of full length SMN2 mRNA
needs to be used every 4 months forever
has clear survival advantages and improved gross motor milestones
best outcomes if treatment started early prior to irreversible loss of motor neurons
Gene therapy
- replacement or correction of the faulty SMN1 gene
“Zolgensma” - single dose
AAV9 vector carries the replacement gene into the body
Dystrophy vs Myopathy
Dystrophy
- degenerative loss and destruction of previously normal muscle “breakdown of muscle
- progressive clinical course
- often abnormal extracellular proteins
- high CK
Myopathy “muscle disease”
- abnormality in intracellular protein architecture
- usually stable muscle weakness
- mild increase in CK
Duchenne Muscular Dystrophy
X linked recessive
Out of frame mutation in DMD gene - encodes dystrophin (usually large insertion or deletion causing frameshift)–> premature stop codon, so bridge function of dystrophin lost
No dystrophin production
Progressive degeneration, fibrosis, muscle fibre death
More common than BMD
Symptoms start at 3-5 years- delayed gross motor milestones, frequent falls, difficulty climbing stairs, toe walking, low mean IQ (may present with learning difficulties or ASD prior to weakness so always do a CK level if any kind of delay!!)
Sleep study then FVC to monitor progression of restrictive lung disease
Steroids can slow progression
Most will need bipap
Becker Muscular Dystrophy
X linked recessive
In frame DMD mutation - residual dystrophin production
Can occasionally affect girls (eg Turners, skewed X lyonisation)
Onset usually teen years
Muscle cramps and pain more prominant
CK usually <5000
Role of dystrophin is to …
bridge actin cytoskeleton to extracellular matrix
DMD complications
achilies tightening
contractures
loss of ambulaiton
resp weakness, nocturnal hypoventialation requiring BIPAP
scoliosis
Dilated cardiomyopathy (100% by 20 years)
examination DMD
Proximal “limb girdle” weakness
Positive Gowers sign
Scapular winging (weakness of thoracoscapular muscles)
Calf pseudohypertrophy
No facial weakness
CK usually >5000
Toe walking
Often present with diffiulty climbing stairs, funny gait developmental delays
Investigations of DMD/BMD
Genetics: dystrophin MLPA, or dystrphin sequencing
Muscle biopsy
Neuroimaging
EMG
- all not usually done
Treatment DMD/BMD
STEROIDS
- slow decline in musce strength and function
stabilise lung function
delay need for NIV and wheelchair
Limb girdle muscular dystrophy
Predominant weakness around shoulder and hip girdle
Onset >2 years, childhood
Variable progression
Present with progressive gait difficulties and scapular winging, positive Gower
No facial weakness
CK usually >5000
Ix: gene panel
Congenital myotonic dystrophy
-CTG Triplet repeat - DMPK gene
-autosomal dominant
- phenotype depends on number of repeats. Normal = 3-37, premutation 37-50, affected >50 , congenital >1000 (less repeats lead to presentation in childhood or adulthood)
- anticipation; number of repeats more likely to increase with female transmission
- often diagnose mother after infant
- progressive weakness, hypotonia, facial weakness, tent mouth, bulbar dysfunction, may require respiratory support, gross motor and cognitive developmental delays ( facial weakness NOT a feature of SMA unless extremely severe)
** Need to examine parents for myotonia
but babies have hypotonia
Mildly elevated CK
Facio-scapular humeral dystrophy
3rd most common muscular dystrophy after myotonic dystrophy and DMD/BMD
- AD inheritance
- present in adolescence
- arm weakness, difficulty raising arms, prominent scapular winging and highly mobile scapula
-facial weakness
- can sometimes progress and cause loss of ambulation
Myotonic dystrophy
50->800 CTG repeats present in childhood or adulhood
progressive muscle weakness
Myotonia
Low IQ
slow gastric emptying, constipation
hypothyroidism
testicular atrophy, male infertility
low IgG
cataracts “ christmas light cataracts”
Arrythmias
fatigue and hypersomnolence
Congenital myopathy
-Non dystrophic muscle disease- non progressive or slowly progressive
-Structural abmormality of muscle - mutation in sarcomeric proteins/contractile apparatus
- Can be evident from birth or early childhood
- generalised weakness, myopathic (tent) facies, bulbar dysfunction, aspiraiton, resp weakness, arthrogyposis, scoliosis, contractures, normal cognition
- may have hx of polyhydramnios and reduced fetal movements
examples: nemaline myopathy, central core disease, centronuclear myopathy
best diagnosed with a gene panel
normal or only mildly elevated CK
Central core myopathy associated with malignant hyperthermia
Charcot Marie Tooth
progressive peripheral neuropahty
- motor and sensory
distal > proximal
reduced distal reflexes- eg absent ankle jerk (distal)
- demyelinating and axonal types
- often present in late childhood/adulthood 5-25 years
- tibeal and peroneal nerves are earliest and most severely affected eg toe walking, progressive weakness of dorsifexion –> foot drop
–> distal weakness, distal wasting, pes cavus, reduced distal reflexes, pain on prolonged ambulation,
palpably enlarged nerves
- <5% become wheelchair dependant, but normal life expectancy
Sensation may be spared until later on in disease
Sensory loss to pinprick and proprioception in a length-dependent manner (glove and stocking)
Demonstrate length-dependent loss by running sharp object up the limb
Gait: high steppage, may have sensory ataxia
Positive Rhomberg’s sign as disease progresses
CMT1A: demyelinating
- damage to myelin sheath –> slowed motor nerve conduction
- PMP22 gene duplication - can be detected on microaray, AD
CMT2: axonal
- axon itself is damaged, low amplitude action potential, but conduction velocity is maintained
Ix: nerve conduction studies (motor and sensory velocities reduced), CK normal, sural nerve biopsy diagnostic, geentics
Rx: pain management, support